Showing results (51-60 of 76) with videos related to

Sort By:
Pageof 8
Mediterranean Journal of Hematology and Infectious Diseases|January 13, 2018
Molecular Heterogeneity in Acute Promyelocytic Leukemia - a Single Center Experience from IndiaNikhil Rabade, Goutham Raval, Shruti Chaudhary, et al.
American Journal of Hematology|November 21, 2024
Treatment-Free Remissions in Children With Chronic Myeloid Leukemia (CML): A Prospective Study From the Tata Memorial Hospital (TMH) Pediatric CML (pCML) CohortNirmalya Roy Moulik, Swaminathan Keerthivasagam, Gaurav Chatterjee, et al.
Cytometry. Part B, Clinical Cytometry|August 20, 2020
Eleven-marker 10-color flow cytometric assessment of measurable residual disease for T-cell acute lymphoblastic leukemia using an approach of exclusionPrashant R Tembhare, Gaurav Chatterjee, Twinkle Khanka, et al.
Indian Journal of Pathology & Microbiology|June 21, 2017
An integrated genomic profile that includes copy number alterations is highly predictive of minimal residual disease status in childhood precursor B-lineage acute lymphoblastic leukemiaNikhil Patkar, P G Subramanian, Prashant Tembhare, et al.
Annals of Hematology|July 21, 2023
Treating relapsed B cell-precursor ALL in children with a setting-adapted mitoxantrone-based intensive chemotherapy protocol (TMH rALL-18 PROTOCOL) - experience from Tata Memorial Hospital, IndiaNirmalya Roy Moulik, Swaminathan Keerthivasagam, Swetha V Velagala, et al.
Cytometry. Part B, Clinical Cytometry|September 8, 2020
Immunophenotypic shift in the B-cell precursors from regenerating bone marrow samples: A critical consideration for measurable residual disease assessment in B-lymphoblastic leukemiaGaurav Chatterjee, Harshini Sriram, Sitaram Ghogale, et al.
Frontiers in Oncology|May 12, 2020
Post-induction Measurable Residual Disease Using Multicolor Flow Cytometry Is Strongly Predictive of Inferior Clinical Outcome in the Real-Life Management of Childhood T-Cell Acute Lymphoblastic Leukemia: A Study of 256 PatientsPrashant R Tembhare, Gaurav Narula, Twinkle Khanka, et al.
Journal for Immunotherapy of Cancer|May 23, 2020
Flow cytometric evaluation of CD38 expression levels in the newly diagnosed T-cell acute lymphoblastic leukemia and the effect of chemotherapy on its expression in measurable residual disease, refractory disease and relapsed disease: an implication for anti-CD38 immunotherapyPrashant Ramesh Tembhare, Harshini Sriram, Twinkle Khanka, et al.
Pediatric Blood & Cancer|July 2, 2021
Efficacy of ready-to-use therapeutic food in malnourished children with cancer: Results of a randomized, open-label phase 3 trialMaya Prasad, Sneha Tandon, Rajul Gala, et al.
Blood Cells, Molecules & Diseases|July 22, 2020
Investigating the clinical, hematological and cytogenetic profile of endoreduplicated hypodiploids in BCP-ALLDhanlaxmi Shetty, Pratibha Kadam Amare, Purvi Mohanty, et al.
Pageof 8